Aspire Biopharma Holdings Common Stock

Aspire Biopharma Holdings (ASBP) currently reports a common stock of $130 as of June 2026. That compares with $5K in the prior-year period — down 97.4% year over year. Use the charts on this page to explore Aspire Biopharma Holdings's common stock history and peer comparisons.

Aspire Biopharma Holdings's common stock decreased from $5K to $130 — a 97.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspire Biopharma Holdings reported $130 in common stock as of June 2026. That compares with $5K in the prior-year period — down 97.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $130, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspire Biopharma Holdings, and consider following ASBP for alerts when major investors trade the stock.